Using human ESCC cell lines as models, reporter gene assays demonstrate that human Mcl-1 promoter activity is decreased by mutation of κB site, specific NF-κB inhibitor Bay11-7082 or dominant inhibitory molecule DNMIκBα in TE-1 and KYSE150 cells. This evidence concerns the gene NFKB1 and esophageal squamous cell carcinoma.